You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 11, 2024

Details for Patent: 11,357,784


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,357,784 protect, and when does it expire?

Patent 11,357,784 protects GALAFOLD and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 11,357,784
Title:Use of migalastat for treating Fabry disease in pregnant patients
Abstract: Provided are methods of treating a patient diagnosed with Fabry disease. Certain methods treat a pregnant patient with a therapeutically effective dose of migalastat or a salt thereof. Other methods treat a patient of childbearing potential with a therapeutically effective dose of migalastat or a salt thereof. Also described are the successful outcomes of pregnancies during which the pregnant patient is treated with migalastat.
Inventor(s): Barth; Jay (Teaneck, NJ)
Assignee: Amicus Therapeutics, Inc. (Philadelphia, PA)
Application Number:16/967,827
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 11,357,784

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amicus Therap Us GALAFOLD migalastat hydrochloride CAPSULE;ORAL 208623-001 Aug 10, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial THE TREATMENT OF FABRY PATIENTS ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 11,357,784

PCT Information
PCT FiledFebruary 06, 2019PCT Application Number:PCT/US2019/016841
PCT Publication Date:August 15, 2019PCT Publication Number: WO2019/157047

International Family Members for US Patent 11,357,784

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019217868 ⤷  Try a Trial
Canada 3090496 ⤷  Try a Trial
China 111971044 ⤷  Try a Trial
European Patent Office 3749307 ⤷  Try a Trial
Japan 2021512906 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.